Loading...
Investigation of a Dipeptidyl Peptidase-4 Inhibitor/Thiazolidinedione Combination Drug for Patients With Type 2 Diabetes and Poor Glycemic Control: Difficulty With Patient Enrollment
BACKGROUND: One of the treatment options for type 2 diabetes mellitus (DM) is a combination drug (CD) that contains the dipeptidyl peptidase-4 inhibitor (DPP4I) alogliptin (AG) together with pioglitazone (PG). This CD can improve impaired insulin secretion and insulin resistance, which are the two m...
Na minha lista:
| Udgivet i: | J Clin Med Res |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elmer Press
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6340677/ https://ncbi.nlm.nih.gov/pubmed/30701000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr3558 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|